Answers are grounded in this paper and cite their sources.
...Although the decision to limit access to breast implants was in with the recommendations of an FDA advisory panel, it was one of the most decisions ever made by the agency. It has left the FDA open to on both flanks: from those who argue that the FDA should not let any have breast implants as long as their safety and effectiveness have not demonstrated, and from those who argue that women ought to be free to the known risks against the personal benefits of an implant and make an choice about whether to have one....
No takes yet. Share an insight, caveat, or question.
David A. Kessler (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: